Encap Drug Delivery and the School of Pharmacy at Queen’s University Belfast have entered into a collaboration to establish a Knowledge Transfer Partnership (KTP) on Hot Melt Extrusion (HME), funded by the Technology Strategy Board and the Scottish Government.
Encap will apply it expertise for the development of HME products and will provide a scientific understanding of the technology to help ensure that products are developed on a rigorous scientific basis and to promote robust and scalable manufacturing processes.
Dr. Jane Fraser said, “I am delighted to be working with Professor David Jones and Dr. Gavin Andrews of QUB, which is recognized as a world leader in the field of HME research. Encap is dedicated to providing world-class development and manufacturing services to its global clients and we are confident that we can establish and grow HME as a mainstream technology for poorly soluble molecules. We believe that this will be a valuable addition to the formulator’s tool box and will fit well with our other enabling technologies.”
Dr. Gavin Andrews said, “Specifically, our intention is that QUB will implement a robust, continuous melt extrusion process capable of engineering solid dispersions. In so doing we aim to complement existing soluble enhancement approaches through the addition of HME and thus bolster Encap’s technologies portfolio.”
Encap Drug Delivery, QUB Establish HME Capability
Published October 8, 2012
blog comments powered by Disqus